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Abstract
Evidence implicating pesticides as causative agents of prostate cancer is controversial, and
specifically, data in young adults is lacking. Hence, we performed a preliminary study evaluating the
relationship between pesticide exposure and prostate cancer in young males. After approval from
the University of North Dakota Institutional Review Board and Human Subjects Committee, a
retrospective study was performed on all young males (</ = 50 years) with a biopsy-proven
diagnosis of carcinoma of the prostate. The records of all patients aged less than/equal to 50 years,
with a diagnosis of adenocarcinoma of the prostate, from January 1991 through December 2001
were reviewed. Pesticide risk assessment interviews were performed by a single member of the
team, for consistency, via telephone on the basis of a pre-determined questionnaire investigating
occupations and hobbies with special emphasis on: Duration of exposure. An exposure index was
calculated for each interviewed subject according to the following formula: hours/day × days/year
× years. Patients with an exposure index >2400 hours were considered as 'exposed.' The 2400
hour cut-off value was chosen on the basis of previous reports indicating that this figure represents
heavy exposure to genotoxic agents. Statistical analysis was obtained using SPSS-10®. Between 1991
and 2001, 61 young males with adenocarcinoma of the prostate were identified, of whom 56
patients with a mean age of 47 years (range: 40–49) had complete records of treatment and could
be contacted for completion of the questionnaire. The most common stage at presentation was
Stage III and the mean Gleason's score was 7.5 (range 5–9). Interestingly, almost a third (16/56,
28.6%) of patients had stage IV disease at presentation. 37/56 (66.1%) patients had 'significant'
exposure in our study. In addition, interestingly, the mean survival in the subgroup of patients with
pesticide exposure was 11.3 months (SD: +/- 2.3 months), while the mean survival in the patients
without pesticide exposure (n = 19) was 20.1 months (SD: +/- 3.1 months), with p-value <0.01.
Although our study is relatively small, it does reveal preliminary evidence linking pesticide exposure
to the early development of, possibly aggressive, prostate adenocarcinoma. Future, larger,
epidemiological studies are needed to confirm the findings of our study.
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Introduction
Adenocarcinoma of the prostate is one of the most fre-
quently diagnosed cancers in men and the second leading
cause of cancer-related deaths in men. The incidence of
prostate carcinoma in the early 1990s increased, mainly
because of an increase in screening for the disease [1].
Many patients with diagnosed prostate cancer have co-
morbid conditions and die of causes other than prostate
cancer [2]. However, this is not true in the case of prostate
cancers occurring at a younger age and with an aggressive
course. Exposure-response relation may be stronger
among young individuals because there is likely to be less
misclassification of both exposure and cause of death
among the young [3]. Also, despite many associations and
attempts to identify specific risk factors for prostate can-
cer, concrete data regarding the etiology of prostate can-
cer, except age, are unavailable. Numerous
epidemiological reports allude to the positive relation
between pesticides and prostate cancer [3–7]. Among
whites the mortality rates in the Midwest and north-cen-
tral regions were significantly higher than the total U.S.
rate. Also, positive correlation was observed for people for
German and Scandinavian ancestry [8]. However, none of
the previously published data addresses the prevalence of
'significant' pesticide exposure among young males with
prostate carcinoma. We decided to study young (</ = 50
years) males in North Dakota and Western Minnesota
(both predominantly rural/farming communities), with
biopsy-proven adenocarcinoma of the prostate, to evalu-
ate the relevance of pesticide exposure and occurrence of
prostate cancer.
Materials and Methods
After approval from the University of North Dakota Insti-
tutional Review Board and Human Subjects Committee, a
retrospective study was performed on all young males (</
= 50 years) with a biopsy-proven diagnosis of carcinoma
of the prostate. The records of all patients aged less than/
equal to 50 years, with a diagnosis of adenocarcinoma of
the prostate, from January 1991 through December 2001
were reviewed. The data collected included the following
variables regarding the patient's cancer history: age, socio-
economic status, family history of cancer (if positive, type
of cancer), smoking, performance score (ECOG), stage of
cancer, treatment modality/modalities for prostate cancer,
metastatic sites (other organs) involved, and associated
malignancies (if any).
Pesticide risk assessment interviews were conducted by a
single member of the team, (for consistency) via tele-
phone, on the basis of a pre-determined questionnaire
investigating occupations and hobbies with special
emphasis on:
(a) Contacts with mutagenic agents including pesticides
(insecticides, herbicides), organic solvents (paints, var-
nishes, solvents and glues) and petroleum products (die-
sels, petrol, oils, greases, dyes, inks and colorings).
(b) Type of exposure (preparation and/or spraying of pes-
ticide solutions, direct handling of solvents containing
materials or petroleum products).
(c) Use of protective measures in the workplace (dissolv-
ing or spraying the pesticide with pressurized containers,
using glues or varnishes with adequate ventilation, etc.).
In the presence of these effective protection measures the
subject was considered as 'non-exposed'.
(d) Duration of exposure. An exposure index was calcu-
lated for each interviewed subject according to the follow-
ing formula: hours/day × days/year × years [9]. Patients
with an exposure index >2400 hours were considered as
'exposed.' The 2400 hour cut-off value was chosen on the
basis of previous reports indicating that this figure repre-
sents heavy exposure to genotoxic agents [10,11]. Statisti-
cal analysis was obtained using SPSS-10®.
Results
Between 1991 and 2001, 61 young males with adenocar-
cinoma of the prostate were identified, of whom 56
patients with a mean age of 47 years (range: 40–49) had
complete records of treatment and could be contacted for
completion of the questionnaire. The most common stage
at presentation was Stage III and the mean Gleason's score
was 7.5 (range 5–9). Interestingly, almost a third (16/56,
28.6%) of patients had stage IV disease at presentation.
Although most patients (n = 40, 70.1%) were asympto-
matic (from a genitourinary perspective) at presentation,
among the patients presenting with symptoms, the most
common presentation was hematuria. Treatment ranged
from radical prostatectomy/definitive radiation therapy to
combination chemotherapy (with estramustine and
docetaxel) and local radiotherapy (for bony metastatic
disease years).
Of the initial 61 patients identified from our database,
only 56 patients/their next of kin could be contacted for
completion of the pesticide risk assessment question-
naire. Surprisingly, 37/56 (66.1%) patients had 'signifi-
cant' exposure in our study. In addition, interestingly, the
mean survival in the subgroup of patients with pesticide
exposure was 11.3 months (range: 5–19 months), while
the mean survival in the patients without pesticide expo-
sure (n = 19) was 20.1 months (range: 9 – 32). The p-
value was significant for decreased survival (<0.01) by t-
test for independent samples (Table 1).Journal of Carcinogenesis 2003, 2 http://www.Carcinogenesis.com/content/2/1/4
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Discussion
Numerous reports over the past few decades have equivo-
cally described the role of pesticides as an etiologic agent
for prostate cancer. But, none specifically address the issue
in young males. Prostate cancer is a biologically heteroge-
neous tumor, with some patients suffering rapid debilita-
tion and death and others never developing clinical
manifestations of the disease [2]. Our study reveals a pos-
sible relation between pesticides and incidence of aggres-
sive prostate cancer resulting in significant morbidity and
mortality in young males. This concurs with numerous
studies, which have shown a possible relation between
occupations involving handling of pesticides and prostate
cancer. Morrison et al, in their large study, have shown
that there is an exposure-response relation between herbi-
cide exposure and prostate cancer mortality. Their data
showed that mortality was related to the number of acres
treated with herbicides. They have further shown that phe-
noxy herbicides may be responsible [3]. Dich et al found
an increased risk of prostate cancer in pesticide applica-
tors (who are exposed to pesticides more than farmers)
[4]. The results of the study by Mills P showed that expo-
sure to the pesticides 'atrazine' and 'captan' correlated sig-
nificantly with an increase in incidence of prostate cancer
in black males [5]. In two separate studies Fleming et al
have reported that pesticide users have a higher risk of
cancers than the general population and amongst cancers
the incidence and mortality due to prostate cancer is espe-
cially increased [6,7].
In predominantly agricultural states like North Dakota
and Western Minnesota, exposure to pesticides is a com-
mon everyday occurrence. Although animal studies dem-
onstrate that many pesticides are carcinogenic, (e.g.
organochlorines, creosote and sulfallate) while others,
notably organochlorines (DDT, chlordane and lindane)
are tumor promoters, human data is limited to a small
number of studies that evaluate individual pesticides [11].
Tessier et al have shown that in human prostate cancer cell
lines LNCaP and PC-3, erbB-2 kinase was activated by pes-
ticides of different chemical classes: the organochlorine
insectides, beta-hexachloro-cyclohexane (beta-HCH),
o,p'-dichloro-diphenyl-trichloroethane (o,p'DDT), hep-
tachlor epoxide, permethrin and chlorothalonil [12].
In occupational epidemiology information is often
required about work histories and occupational exposures
of study subjects. Objective sources are the best way to
gather this data, but, unfortunately, subjects themselves
are the only source of the required data. We realize that as
with most questionnaire-based studies, a drawback of our
study-design is the distinct possibility of a recall bias
among the case population. In addition, in cases where
the patient was deceased, the data was obtained from the
next of kin, who may or may not have had detailed knowl-
edge regarding pesticide exposure of the subject in ques-
tion. Repeatability of self reported data on occupational
exposure has been shown to be high in previous studies
[13,14]. Also, accuracy of job history was not influenced
by level of education, socioeconomic status or age, espe-
cially young males [15–18]. Interviewing technique plays
a central role in improving accuracy of the recall and is
under the control of the investigator [19]. We tried to min-
imize the effect of interviewing technique on the results
by having one single investigator conduct all the inter-
views. Also, we used prompted questions, rather than
open-ended question during the collection of exposure-
data as that has been shown to decrease recall bias [20].
Finally, another potential drawback to our study was the
fact that although we gathered enough data regarding the
extent of pesticide (insecticide/herbicide) exposure, while
implementing our questionnaire, we failed to investigate
the extent of exposure to specific pesticides/their
components.
Conclusions
Due to the relatively small number of patients included in
our study, our results should be considered as only pre-
liminary evidence linking pesticide exposure to the early
development of prostatic carcinoma. It is possible that
exposure to pesticide(s)/pesticide components leads to
alteration of specific biomarker profiles {i.e. her-2/neu,
VEGF (vascular endothelial growth factor), UPA-r (uroki-
nase plasminogen activator-receptor)} leading to the
development of aggressive adenocarcinoma of the
prostate. We are currently in the process of testing specific
pesticide components in PC-3 and LNCaP cells to evalu-
ate for overexpression of the above biomarkers. Future,
larger, epidemiologic studies would also be helpful to
determine which pesticide(s)/pesticide components are
indeed associated with the early progression of adenocar-
cinoma of the prostate, and eventually to diminished sur-
vival, so that proper preventative measures may be
adopted.
Table 1: Table showing comparison of survival between exposed and nonexposed males with prostate cancer: (p-value < 0.01).
Number (n) Mean Survival (months) Standard Deviation (+/- months)
Males with significant pesticide exposure 37 11.3 2.3
Males without significant pesticide exposure 19 20.1 3.1Publish with BioMed Central    and   every 
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